Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
UCSF Benioff Children's Hospital, Oakland, California University of Minnesota, Minneapolis, Minnesota Japan
National Center for Child Health and Development, Setagaya City, Tokyo South Korea
Ajou University Medical Center, Suwon, Gyeongi-do Samsung Medical Center, Seoul